Determination of cytochrome P450 3A4/5 activity in vivo with dextromethorphan N‐demethylation

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Clinical pharmacology and therapy

• Publication date

  1996-10-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0009-9236(96)90194-0PMID 8873685
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phenotypic Differences in Dextromethorphan Metabolism

  2004cited by this paper
• Dextromethorphan as an in vivo probe for the simultaneous determination of CYP2D6 and CYP3A activity.

  1996cited by this paper
• The erythromycin breath test predicts the clearance of midazolam

  1995cited by this paper
• Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients.

  1994cited by this paper
• Interindividual variation in the isomerization of 4-hydroxytamoxifen by human liver microsomes: involvement of cytochromes P450.

  1994cited by this paper
• Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter- and intraindividual hepatic CYP3A variability after liver transplantation.

  1994cited by this paper
• Noninvasive tests of CYP3A enzymes.

  1994cited by this paper
• Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel. Lack of prediction by the erythromycin breath test.

  1994cited by this paper
• Characterization of dextromethorphan N-demethylation by human liver microsomes. Contribution of the cytochrome P450 3A (CYP3A) subfamily.

  1994cited by this paper
• CYP2D6- and CYP3A-dependent metabolism of dextromethorphan in humans.

  1993cited by this paper
• Absence of correlations among three putative in vivo probes of human cytochrome P4503A activity in young healthy men

  1993cited by this paper
• Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences.

  1993cited by this paper
• Risk of needle-stick injuries in the transmission of hepatitis C virus in hospital personnel.

  1992cited by this paper
• Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction

  1992cited by this paper
• The human hepatic cytochromes P450 involved in drug metabolism.

  1992cited by this paper
• First-pass metabolism of cyclosporin by the gut.

  1991cited by this paper
• Simultaneous Determination of Dextromethorphan and Three Metabolites in Plasma and Urine Using High‐Performance Liquid Chromatography with Application to Their Disposition in Man

  1990cited by this paper
• Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3).

  1990cited by this paper
• Cyclosporine.

  1989cited by this paper
• Inhibition of alfentanil metabolism by erythromycin

  1989cited by this paper
• Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients.

  1989cited by this paper
• Drug therapy: cyclosporine

  1989cited by this paper
• Cyclosporin-erythromycin interaction in normal subjects.

  1987cited by this paper
• Genetically determined polymorphisms in drug oxidation

  1986cited by this paper
• A pharmacokinetic drug interaction between erythromycin and triazolam.

  1986cited by this paper
• Polymorphic dextromethorphan metabolism: Co‐segregation of oxidative O‐demethylation with debrisoquin hydroxylation

  1985cited by this paper
• Inter-individual variation in the metabolism of dextromethorphan

  1983cited by this paper

• Novel Approaches to Characterize Individual Drug Metabolism and Advance Precision Medicine

  2023cites this paper
• Physiologically based pharmacokinetic (PBPK) modeling of the role of CYP2D6 polymorphism for metabolic phenotyping with dextromethorphan

  2022cites this paper
• Effect of Vernonia Amygdalina Leaf on Cytochrome P450 2D6- and 3A4-Mediated Metabolism of Dextromethorphan in Healthy Nigerian Subjects

  2021cites this paper
• Exploring the Use of Serum‐Derived Small Extracellular Vesicles as Liquid Biopsy to Study the Induction of Hepatic Cytochromes P450 and Organic Anion Transporting Polypeptides

  2021cites this paper
• Oral Yohimbine as a New Probe Drug to Predict CYP2D6 Activity: Results of a Fixed-Sequence Phase I Trial

  2020cites this paper
• Pharmacokinetics of Drug Metabolites

  2019cites this paper
• Profiling of Drug-Metabolizing Enzymes and Transporters in Human Tissue Biopsy Samples: A Review of the Literature

  2019cites this paper
• In vivo Phenotyping Methods: Cytochrome P450 Probes with Emphasis on the Cocktail Approach.

  2017cites this paper
• Endogenous and xenobiotic metabolic stability of primary human hepatocytes in long-term 3D spheroid cultures revealed by a combination of targeted and untargeted metabolomics

  2017cites this paper
• Managing interactions between cognitive enhancers and other psychotropics

  2017cites this paper
• Multiplex Phenotyping for Systems Medicine: A One-Point Optimized Practical Sampling Strategy for Simultaneous Estimation of CYP1A2, CYP2C9, CYP2C19, and CYP2D6 Activities Using a Cocktail Approach

  2016cites this paper
• Prediction of in vivo metabolite disposition and complex metabolite-dependent drug-drug interactions

  2013cites this paper
• A Physiologically Based Pharmacokinetic Model to Predict Disposition of CYP2D6 and CYP1A2 Metabolized Drugs in Pregnant Women

  2013influential citation
• A herbal‐drug interaction study of keishi‐bukuryo‐gan, a traditional herbal preparation used for menopausal symptoms, in healthy female volunteers

  2012influential citation
• Prediction of Relative In Vivo Metabolite Exposure from In Vitro Data Using Two Model Drugs: Dextromethorphan and Omeprazole

  2012influential citation
• Simultaneous quantification of dextromethorphan and its metabolites dextrorphan, 3-methoxymorphinan and 3-hydroxymorphinan in human plasma by ultra performance liquid chromatography/tandem triple-quadrupole mass spectrometry.

  2011influential citation
• Dynamische Modellierung und Simulation des Arzneimittelmetabolismus in humanen Leberzellen: Identifizierbarkeit, Robustheit und inter-individuelle Variabilität

  2011influential citation
• Dextromethorphan as a phenotyping test to predict endoxifen exposure in patients on tamoxifen treatment.

  2011cites this paper
• Metabolism of dextrorphan by CYP2D6 in different recombinantly expressed systems and its implications for the in vitro assessment of dextromethorphan metabolism.

  2009cites this paper
• Respuesta terapéutica a mefloquina, estado nutricional y variantes alélicas del gen CYP3A4 en pacientes con malaria falciparum no complicada; Antioquia (Colombia)

  2009cites this paper
• The Biochemistry of Drug Metabolism – An Introduction

  2008cites this paper
• Ontogeny of Dextromethorphan O‐ and N‐demethylation in the First Year of Life

  2007cites this paper
• Reboxetine and cytochrome P450--comparison with paroxetine treatment in humans.

  2007cites this paper
• Simultaneous analysis of dextromethorphan and its three metabolites in human plasma using an improved HPLC method with fluorometric detection.

  2007cites this paper
• Development of the “Inje Cocktail” for High‐throughput Evaluation of Five Human Cytochrome P450 Isoforms in vivo

  2007cites this paper
• The effect of Shoseiryuto, a traditional Japanese medicine, on cytochrome P450s, N-acetyltransferase 2 and xanthine oxidase, in extensive or intermediate metabolizers of CYP2D6

  2007cites this paper
• CYP: cytochrome P450; HT: hexahistidine-tagged; ES/LC-MS: electrospray ionization/liquid chromatography mass spectrometry; PMSF: phenylmethylsulfonyl fluoride; CHAPS: 3-[(3-cholamidopropyl)dimethyl-ammonio]-1-propanesulfonate; EDDP: 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine; TFA: trifluoroac

  2006cites this paper
• EXPRESSION, PURIFICATION, AND CHARACTERIZATION OF MOUSE CYP2D22

  2006cites this paper
• EXPRESSION , PURIFICATION , AND CHARACTERIZATION OF MOUSE CYP 2 D 22

  2006cites this paper
• Evaluation of dextromethorphan metabolism using hepatocytes from CYP2D6 poor and extensive metabolizers.

  2005cites this paper
• Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy.

  2005cites this paper
• Phenotypical expression of CYP2D6 in amerindians of tepehuano origin from Durango, Mexico.

  2005cites this paper
• DEXTROMETHORPHAN TO DEXTRORPHAN URINARY METABOLIC RATIO DOES NOT REFLECT DEXTROMETHORPHAN ORAL CLEARANCE

  2005cites this paper
• Measurement of CYP2D6 and CYP3A4 activity in vivo with dextromethorphan: sources of variability and predictors of adverse effects in 419 healthy subjects

  2005cites this paper
• Effect of low‐dose ritonavir (100 mg twice daily) on the activity of cytochrome P450 2D6 in healthy volunteers

  2005cites this paper
• Comparison of Various Urine Collection Intervals for Caffeine and Dextromethorphan Phenotyping in Children

  2004cites this paper
• Sufentanil in the ICU setting

  2004cites this paper
• Integrating in vitro kinetic data from compounds exhibiting induction, reversible inhibition and mechanism-based inactivation: in vitro study design.

  2004cites this paper
• The Effect of Echinacea (Echinacea purpurea Root) on Cytochrome P450 Activity in Vivo

  2004influential citation
• Drug-Metabolizing Enzymes and P-Glycoprotein

  2004cites this paper
• Application of Pharmacokinetics to Improve Antiretroviral Treatment.

  2003cites this paper
• Approaches to Studying the Development of Drug Metabolism in Children

  2002cites this paper
• The effect of grapefruit juice and seville orange juice on the pharmacokinetics of dextromethorphan: the role of gut CYP3A and P-glycoprotein.

  2002cites this paper
• Evaluation of dextromethorphan N-demethylation activity as a biomarker for cytochrome P450 3A activity in man.

  2002cites this paper
• Effect of Terbinafine on the Pharmacokinetics and Pharmacodynamics of Desipramine in Healthy Volunteers Identified as Cytochrome P450 2D6 (CYP2D6) Extensive Metabolizers

  2002cites this paper
• A sensitive LC-MS/MS assay for the determination of dextromethorphan and metabolites in human urine--application for drug interaction studies assessing potential CYP3A and CYP2D6 inhibition.

  2002cites this paper
• CYP3A4 variant alleles in white individuals with low CYP3A4 enzyme activity

  2002cites this paper
• Sertraline pharmacokinetics and dynamics in adolescents.

  2002cites this paper
• Ontogeny and Pharmacogenetics: Determinants of Age-Associated Differences in Drug Clearance During Human Development

  2002cites this paper
• Lack of Gender Differences and Large Intrasubject Variability in Cytochrome P450 Activity Measured by Phenotyping with Dextromethorphan

  2001influential citation
• Mechanism-Based Inhibition of Human Cytochromes P450: In Vitro Kinetics and In Vitro—In Vivo Correlations

  2001cites this paper
• Comparative contribution to dextromethorphan metabolism by cytochrome P450 isoforms in vitro: can dextromethorphan be used as a dual probe for both CTP2D6 and CYP3A activities?

  2001cites this paper
• In vivo effect of clarithromycin on multiple cytochrome P450s.

  2001cites this paper
• Polymorphic drug metabolising enzymes

  2001cites this paper
• Chapter Cytochrome P 450 3 A . Ontogeny and drug disposition 2

  2001cites this paper
• In-vivo indices of CYP2D6 activity: comparison of dextromethorphan metabolic ratios in 4-h urine and 3-h plasma

  2000cites this paper
• In vivo and in vitro induction of human cytochrome P4503A4 by dexamethasone

  2000cites this paper
• Pharmacokinetics and pharmacodynamics of IFN-beta 1a in healthy volunteers.

  2000cites this paper
• Steady state plasma levels of the enantiomers of trimipramine and of its metabolites in CYP2D6-, CYP2C19- and CYP3A4/5-phenotyped patients.

  2000cites this paper
• Can oral midazolam predict oral cyclosporine disposition?

  2000cites this paper
• Problems and perspectives of phenotyping for drug-metabolizing enzymes in man.

  2000cites this paper
• Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes.

  2000cites this paper
• Evaluation of analytical and clinical performance of a dual-probe phenotyping method for CYP2D6 polymorphism and CYP3A4 activity screening.

  2000cites this paper
• In vivo effects of interleukin‐10 on human cytochrome P450 activity

  2000cites this paper
• Pharmacokinetics and Pharmacodynamics of IFN-β1a in Healthy Volunteers

  2000cites this paper
• Cytochrome P450 3A

  1999cites this paper
• In-vivo indices of enzyme activity: the effect of renal impairment on the assessment of CYP2D6 activity.

  1999cites this paper
• Lack of single-dose disulfiram effects on cytochrome P-450 2C9, 2C19, 2D6, and 3A4 activities: evidence for specificity toward P-450 2E1.

  1999cites this paper
• Assessment of CYP2D6 and CYP2C19 activity in vivo in humans: A cocktail study with dextromethorphan and chloroguanide alone and in combination

  1999cites this paper
• The physiological and pharmacological roles of cytochrome P450 isoenzymes

  1999cites this paper
• A Urine Metabolic Ratio of Dextromethorphan and 3‐Methoxymorphinan as a Probe for CYP3A Activity and Prediction of Cyclosporine Clearance in Healthy Volunteers

  1999influential citation
• Nortriptyline E‐10‐Hydroxylation in Vitro Is Mediated by Human CYP2D6 (High Affinity) and CYP3A4 (Low Affinity): Implications for Interactions with Enzyme‐Inducing Drugs

  1999cites this paper
• Fully automated analysis of activities catalysed by the major human liver cytochrome P450 (CYP) enzymes: assessment of human CYP inhibition potential.

  1999cites this paper
• Investigation of terbinafine as a CYP2D6 inhibitor in vivo

  1999cites this paper
• Limitations of dextromethorphan N-demethylation as a measure of CYP3A activity.

  1999cites this paper
• Intra‐individual variability and influence of urine collection period on dextromethorphan metabolic ratios in healthy subjects

  1999cites this paper
• Multiple Human Cytochromes Contribute to Biotransformation of Dextromethorphan In‐vitro: Role of CYP2C9, CYP2C19, CYP2D6, and CYP3A

  1998cites this paper
• In vitro and in vivo drug interactions involving human CYP3A.

  1998cites this paper
• Renal clearance, tissue distribution, and CA-125 responses in a phase I trial of suramin.

  1998cites this paper
• Interpretation of Postmortem Dextromethorphan Concentrations—a Review of Case Data and the Literature

  1998cites this paper
• 16 α-Hydroxylation of estrone by human cytochrome P 4503 A 4 / 5

  1998cites this paper
• IN VITRO AND IN VIVO DRUG INTERACTIONS INVOLVING HUMAN CYP 3 A

  1998cites this paper
• 16Alpha-hydroxylation of estrone by human cytochrome P4503A4/5.

  1998cites this paper
• Influence of stiripentol on cytochrome P450‐mediated metabolic pathways in humans: In vitro and in vivo comparison and calculation of in vivo inhibition constants

  1997cites this paper
• CYP2D6 genotype and phenotyping by determination of dextromethorphan and metabolites in serum of healthy controls and of patients under psychotropic medication.

  1997cites this paper